135 related articles for article (PubMed ID: 33361866)
1. Clinical Application of the Ratio of Serum Bone Isoform to Total Alkaline Phosphatase in General Practice.
Yokota Y; Nishimura Y; Ando A; Hanayama Y; Hasegawa K; Hagiya H; Ogawa H; Obika M; Ueda K; Otsuka F
Acta Med Okayama; 2020 Dec; 74(6):467-474. PubMed ID: 33361866
[TBL] [Abstract][Full Text] [Related]
2. Elevation of serum alkaline phosphatase (ALP) level in postmenopausal women is caused by high bone turnover.
Mukaiyama K; Kamimura M; Uchiyama S; Ikegami S; Nakamura Y; Kato H
Aging Clin Exp Res; 2015 Aug; 27(4):413-8. PubMed ID: 25534961
[TBL] [Abstract][Full Text] [Related]
3. Analysis of bone alkaline phosphatase as a marker for the diagnosis of osteoporosis in men under androgen ablation.
Morote J; Trilla E; Esquena S; Abascal JM; Segura RM; Catalan R; Encabo G; Reventós J
Int J Biol Markers; 2003; 18(4):290-4. PubMed ID: 14756545
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of alkaline phosphatase and bone-specific alkaline phosphatase in breast cancer: A systematic review and meta-analysis.
Jiang C; Hu F; Xia X; Guo X
Int J Biol Markers; 2023 Mar; 38(1):25-36. PubMed ID: 36775971
[TBL] [Abstract][Full Text] [Related]
5. Higher serum bone alkaline phosphatase as a predictor of mortality in male hemodialysis patients.
Kobayashi I; Shidara K; Okuno S; Yamada S; Imanishi Y; Mori K; Ishimura E; Shoji S; Yamakawa T; Inaba M
Life Sci; 2012 Jan; 90(5-6):212-8. PubMed ID: 22154904
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of alkaline phosphatase and bone-specific alkaline phosphatase for metastases in breast cancer: a systematic review and meta-analysis.
Jiang C; Hu F; Li J; Gao G; Guo X
Breast Cancer Res Treat; 2023 Nov; 202(2):233-244. PubMed ID: 37522998
[TBL] [Abstract][Full Text] [Related]
7. Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients.
Ureña P; Hruby M; Ferreira A; Ang KS; de Vernejoul MC
J Am Soc Nephrol; 1996 Mar; 7(3):506-12. PubMed ID: 8704118
[TBL] [Abstract][Full Text] [Related]
8. The relationship between glucose metabolism, metabolic syndrome, and bone-specific alkaline phosphatase: a structural equation modeling approach.
Cheung CL; Tan KC; Lam KS; Cheung BM
J Clin Endocrinol Metab; 2013 Sep; 98(9):3856-63. PubMed ID: 23796564
[TBL] [Abstract][Full Text] [Related]
9. Multiparameter analysis of serum levels of C-telopeptide crosslaps, bone-specific alkaline phosphatase, cathepsin K, osteoprotegerin and receptor activator of nuclear factor κB ligand in the diagnosis of osteoporosis.
Piatek S; Adolf D; Wex T; Halangk W; Klose S; Westphal S; Amthauer H; Winckler S
Maturitas; 2013 Apr; 74(4):363-8. PubMed ID: 23391500
[TBL] [Abstract][Full Text] [Related]
10. Biochemical markers of bone formation in patients with plasma cell dyscrasias and benign osteoporosis.
Woitge HW; Horn E; Keck AV; Auler B; Seibel MJ; Pecherstorfer M
Clin Chem; 2001 Apr; 47(4):686-93. PubMed ID: 11274019
[TBL] [Abstract][Full Text] [Related]
11. Bone-specific alkaline phosphatase protein, total alkaline phosphatase activity and lactate dehydrogenase in sera of patients with sickle cell disease.
Bolarin DM
Haematologia (Budap); 2001; 31(1):51-6. PubMed ID: 11345404
[TBL] [Abstract][Full Text] [Related]
12. Markers of bone metabolism are affected by renal function and growth hormone therapy in children with chronic kidney disease.
Doyon A; Fischer DC; Bayazit AK; Canpolat N; Duzova A; Sözeri B; Bacchetta J; Balat A; Büscher A; Candan C; Cakar N; Donmez O; Dusek J; Heckel M; Klaus G; Mir S; Özcelik G; Sever L; Shroff R; Vidal E; Wühl E; Gondan M; Melk A; Querfeld U; Haffner D; Schaefer F;
PLoS One; 2015; 10(2):e0113482. PubMed ID: 25659076
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease.
Garnero P; Delmas PD
J Clin Endocrinol Metab; 1993 Oct; 77(4):1046-53. PubMed ID: 8104954
[TBL] [Abstract][Full Text] [Related]
14. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y
Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265
[TBL] [Abstract][Full Text] [Related]
15. The distinction of bone and liver isoenzymes of alkaline phosphatase in serum using a monoclonal antibody.
Seabrook RN; Bailyes EM; Price CP; Siddle K; Luzio JP
Clin Chim Acta; 1988 Mar; 172(2-3):261-6. PubMed ID: 3370840
[TBL] [Abstract][Full Text] [Related]
16. Can Bone-Specific Alkaline Phosphatase be a Marker of Vascular Calcification in Type 2 Diabetes Mellitus?
Raizada N; Aslam M; Mishra BK; Chawla D; Madhu SV
Indian J Endocrinol Metab; 2023; 27(2):127-132. PubMed ID: 37292071
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum.
Gomez B; Ardakani S; Ju J; Jenkins D; Cerelli MJ; Daniloff GY; Kung VT
Clin Chem; 1995 Nov; 41(11):1560-6. PubMed ID: 7586543
[TBL] [Abstract][Full Text] [Related]
18. Comparison of total and bone-specific alkaline phosphatase in patients with nonskeletal disorder or metabolic bone diseases.
Woitge HW; Seibel MJ; Ziegler R
Clin Chem; 1996 Nov; 42(11):1796-804. PubMed ID: 8906079
[TBL] [Abstract][Full Text] [Related]
19. A variation in Bone Alkaline Phosphatase levels that correlates positively with bone loss and normal levels of aminoterminal propeptide of collagen I in girls with anorexia nervosa.
Calero JA; Muñoz MT; Argente J; Traba ML; Méndez-Dávila C; García-Moreno C; de la Piedra C
Clin Chim Acta; 1999 Jul; 285(1-2):121-9. PubMed ID: 10481928
[TBL] [Abstract][Full Text] [Related]
20. Comparison of two bone markers with growth evolution in 74 girls with central precocious puberty.
Vincent A; Souberbielle JC; Brauner R
BMC Pediatr; 2018 Jul; 18(1):224. PubMed ID: 29986677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
